As many growing biotech organizations near launch, they need an operational foundation that can support growth. The first signs of this transition appear gradually when spreadsheets and point solutions accumulate, teams spend more time reconciling data while visibility across the business declines. This is often when leaders begin asking a more important question: When is the right time to invest in an enterprise platform like SAP? Download the ERP Planning for Pre-Commercial Biotech Companies guide to explore how pre-commercial biotech companies can build a scalable operational foundation without adding unnecessary complexity. Below, we’re sharing an outline of what to expect from the guide.

ERP Planning for Pre-Commercial Biotech

There’s no single company size or clinical milestone that determines when an enterprise platform becomes appropriate. The right entry point depends on the commercialization strategy, the operating model, and the level of regulatory rigor the company must support. It also depends on where the organization expects to be in the years ahead. 

Contrary to common perception, implementing SAP is no longer an all-or-nothing decision reserved for global pharmaceutical manufacturers. Modern cloud-based solutions like SAP Cloud ERP allow pre-commercial biotech organizations to begin with priority capabilities, such as finance and reporting, then expand as the business grows. 

1. The New Reality of Pre-Commercial Biotech – Growth Creates Operational Complexity, Operational Readiness Is a Competitive Advantage, The Role of Enterprise Technology  

2. When Is the Right Time for SAP? – Building a Scalable SAP Journey, Recognizing the Tipping Point, Choosing the Right Decision Horizon, Rethinking SAP

3. A Smarter Approach to SAP Implementation – Avoid the “Big Bang” Mentality, Standardize Before You Customize

4. Why SAP Is Different for Life Sciences – Designed for Complexity, Supporting Compliance, Building Resilient Supply Chains

5. Expanding Value Over Time – Turning Data into Action, SAP Business AI, A Platform that Evolves with the Business

Download the Guide

No two biotech companies follow the same path to commercialization. Identifying the right SAP entry point requires considering commercialization strategy alongside the operating model. It also requires considering validation implications, current systems, and future capabilities. That assessment helps leaders determine whether SAP fits the destination and when introducing it creates the greatest business value with the least disruption.

Drawing on industry experience and proven SAP best practices, this guide helps life sciences organizations align technology decisions with their commercialization plans. Early planning can help companies scale operations while maintaining focus on bringing therapies to patients.